BARBARA WAHL: Open Payments
NPI 1265955173 · BELLEVUE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,164 in 45 payments from 10 companies in 2025. Trend: 2023 $34 · 2024 $542 · 2025 $1,164
Food & beverage: $1,164
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 7 | $337 |
| Indivior Inc. | 11 | $242 |
| ABBVIE INC. | 8 | $137 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $137 |
| Teva Pharmaceuticals USA, Inc. | 4 | $136 |
| Vanda Pharmaceuticals Inc. | 4 | $83 |
| Alkermes, Inc. | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Orexo US, Inc. | 1 | $18 |
Products named: BRIXADI, SUBLOCADE, VRAYLAR, CAPLYTA, UZEDY, FANAPT, VIVITROL, SPRAVATO.
Industry payments across OH — which companies pay providers there.
